CM518D1

· Keymed Biosciences Co. Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CM518D1, covering 2025-11-17 to 2025-11-17. Get the full timeline:

Most recent: Clinical Trial Update: Study of CM518D1 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]